Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

BACKGROUND: The American Joint Committee on Cancer staging and other prognostic tools fail to account for stage-independent variability in outcome. We developed a prognostic classifier adding Immunoscore to clinicopathological and molecular features in patients with stage III colon cancer. METHODS:...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JNCI Cancer Spectr
Glavni autori: Sinicrope, Frank A, Shi, Qian, Hermitte, Fabienne, Zemla, Tyler J, Mlecnik, Bernhard, Benson, Al B, Gill, Sharlene, Goldberg, Richard M, Kahlenberg, Morton S, Nair, Suresh G, Shields, Anthony F, Smyrk, Thomas C, Galon, Jerome, Alberts, Steven R
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7236783/
https://ncbi.nlm.nih.gov/pubmed/32455336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa023
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items